Abstract Lipid mediators derived from omega-3 polyunsaturated fatty acids (n-3 PUFA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are critical mediators of inflammation. In contrast to EPA and DHA, the bioavailability of their lipid mediator derivatives remains unstudied. Oral, intravenous (IV), and intraduodenal administration of stable isotope labeled n-3 PUFA, and lipid mediators was used to establish their bioavailability, half-lives, and absorption routes in rats.